48 results on '"Phatak H"'
Search Results
2. EE51 Rethinking Economic Evaluation in Amyotrophic Lateral Sclerosis Treatment: Embracing Alternative Model Conceptualizations
3. PRO18 A Systematic Literature Review of the Economic Burden and Cost Drivers in Pulmonary Arterial Hypertension
4. PCN171 COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)
5. 1284P - Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings
6. TP1 REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC UROTHELIAL CANCER RECEIVING SECOND-LINE THERAPY IN THE US VETERAN POPULATION
7. PCN317 REAL-WORLD STUDY OF METASTATIC MERKEL CELL CARCINOMA PATIENTS RECEIVING CHECKPOINT INHIBITORS (CPIS) VS. CHEMOTHERAPY TREATMENTS
8. PCN314 REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION
9. PCN339 - SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER): TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN THE UNITED STATES
10. PCN26 - ASSESSING THE POTENTIAL VALUE OF AN INNOVATIVE ONCOLOGY THERAPY FROM THE HEALTH TECHNOLOGY ASSESSMENT (HTA) PERSPECTIVE: MARRYING CLINICAL VALUE FRAMEWORKS WITH ECONOMIC ASSESSMENT METHODOLOGY
11. PCN243 - Patient Characteristics And Treatment Patterns From Spear-Bladder: Study Informing Treatment Pathway Decision In Bladder Cancer
12. CN4 - Projecting Overall Survival (OS) With Immuno-Oncology (IO) Treatments: Application of Alternative Approaches in Metastatic Merkel Cell Carcinoma (MMCC)
13. CP3 - Assessment-Time Bias: Statistical Approaches to Adjusting for Between-Trial Differences in the Schedule of Assessment for Disease Progression In Immuno-Oncology Trials
14. PCN70 - Budget Impact Analysis of Avelumab in Patients with Metastatic Merkel Cell Carcinoma in The US
15. PCN20 - Merkel Cell Cancer: Poor Response To Chemotherapy Exposes Significant Unmet Need
16. PCN15 - Second-Line Therapy In Patients with Locally Advanced or Metastatic Urothelial Cancer: A Systematic Literature Review
17. PCV68 - Focus Groups Exploring Experiences with and Preferences for Oral Anticoagulants in People with Nonvalvular Atrial Fibrillation
18. PRM208 - Simulated Treatment Comparison of Time-To-Event (And Other Non-Linear) Outcomes
19. PCV123 - Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France
20. PCV131 - Venous Thromboembolism Treatment Patterns In The European Union (Eu) Region: 2013 Retrospective Chart Extraction
21. PCV15 - Comparison Of Apixaban, Dabigatran, Rivaroxaban, And Edoxaban In The Acute Treatment And Prevention Of Venous Thromboembolism: Systematic Review And Network Meta-Analysis
22. PCV9 - Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation
23. PCV5 - Clinical Outcomes And Treatment Patterns of Venous Thromboembolism Among Cancer Patients In A Large Commercial Database
24. PCV45 - Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation
25. PCV3 - Health Care Utilization and Costs After Warfarin Discontinuation Among Patients with Non-Valvular Atrial Fibrillation
26. PCV161 - Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants
27. PCV133 - Literature Review Of Pro Measures Assessing Anticoagulant Therapy
28. PCV25 - Risk Factors Associated With Venous Thromboembolism Recurrence In A European Population
29. PCV14 - Lifetime Clinical Events Avoided And Resource Utilization With Apixaban Compared To Low-Molecular-Weight Heparin Followed By A Vitamin K Antagonist For The Treatment And Prevention Of Venous Thromboembolism
30. PCV67 - Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation
31. PCV31 - Anticoagulant Use And Bleeding Risk In Patients With Venous Thromboembolism: A Nested Case-Control Study
32. RI2 - Warfarin Discontinuation and Stroke Risk Among Patients with Non-Valvular Atrial Fibrillation
33. PCV122 - Quality of Life in Patients with Venous Thromboemoblism: A Systematic Literature Review
34. PCV44 - Economic Burden of Venous Thromboemoblism Across Patient Populations: A Literature Review
35. PCV22 - Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United States
36. PCV16 - Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature Review
37. PCV117 - Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation
38. PCV13 - Recurrence and risk factors in hospitalized patients with acute venous thromboembolism: A claims database analysis
39. PCV5 - Epidemiology and mortality of venous thromboembolism across patient populations: A systematic literature review
40. PCV19 Venous Thromboembolism Prophylaxis and Clinical Consequences in Hospitalized Medically Ill Patients
41. PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
42. PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
43. PCV125 UTILIZATION PATTERNS FOR ANTIARRHYTHMIC DRUGS IN BIG 5 EU MARKETS: TEMPORAL ANALYSIS FROM 2005 TO 2009
44. PCV64 IMPACT OF WORSENING RENAL FUNCTION ON HEALTH CARE UTILIZATION OBSERVED AMONG HOSPITALIZED HEART FAILURE PATIENTS
45. Abstract: P759 MODELING ATTAINMENT OF NORMAL LIPID LEVELS IN SWISS PATIENTS RECEIVING ER NIACIN/LAROPIPRANT ADDED TO STATIN THERAPY
46. PO16-441 DYSLIPIDEMIA AMONG STATIN-TREATED PATIENTS EXPERIENCING CARDIOVASCULAR AND CEREBROVASCULAR EVENTS IN THE UK
47. PO16-422 MIXED DYSLIPIDEMIA AMONG FRENCH PATIENTS USING LIPID-LOWERING THERAPY
48. PCV59 LIPID TESTING AMONG PATIENTS RECEIVING FIRST-EVER STATIN THERAPY IN UK GENERAL PRACTICES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.